S66G (p.Ser66Gly) variant of CYP51A1 (Lanosterol 14-alpha demethylase)

S66G (p.Ser66Gly) in CYP51A1 (Lanosterol 14-alpha demethylase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided; not specified. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data and structural context.

S66G (p.Ser66Gly) variant details